Evaluation of treatment on unilateral cleft lip and palate complete dextra to the quality of life: 4-year follow-up: Case report
Abstract
Treatment for the patient with cleft lip and palate (CLP) requires an interdisciplinary team concerned with improving the patient’s quality of life. This case evaluates the influence of comprehensive therapy on unilateral CLP complete dextra within a 4-year follow-up. A 4-days-old female patient visited a government hospital in Bandung after being referred to a pediatric clinic in the same hospital. The patient was born at 3.2 kg weight with no underlying medical conditions or syndromes. Intraoral examination revealed cleft soft and hard palate and separated alveolar segment. Extraoral examination revealed cleft lip unilateral dextra and shortened columella. The patient underwent compre-hensive therapy including presurgical NAM (PNAM), labioplasty, nasoalveolar molding (NAM), veloplasty, speech therapy, and palatoplasty. It is concluded that early treatment of PNAM reduces the severity of the orofacial deformi-ty, induced the reposition of soft & hard tissue and there’s an improvement in intelligibility and production of pharyng-eal sounds and velopharyngeal closure when using intravelar veloplasty in palatal repair along with NAM. In the fourth year of life, the patient has capable on communicates with intelligibility pronounce with relative adequate arch.
Published
2023-12-01
Section
Articles
The copyright of the received article shall be assigned to the journal as the publisher of the journal. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
This work is licensed under a Creative Commons Attribution 4.0 International License.